Company
United StatesPublic company, NYSE: MCKMcKesson Corporation (NYSE: MCK), Anchorage, AK – FDA Inspections
Inspection records and compliance data for McKesson Corporation in Anchorage, Alaska. 2 FDA inspections on record, last inspected August 24, 2023. Publicly traded as NYSE: MCK.
Company Profile
This profile covers McKesson Corporation based in Anchorage, Alaska, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected November 9, 2012. Last inspected August 24, 2023.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 24, 2023 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 1218251 |
| November 9, 2012 | NAI | Human Drugs · Drug Quality Assurance | 807100 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
McKesson Corporation
Stock ticker
MCK
Exchange
NYSE
Share price
$1,077.29
Market cap
$124.4B
Price as of
November 6, 2026
FEI Number
3004399761
Address
5491 Electron Dr Ste A, Anchorage, Alaska 99518, United States
Country
United States
ID: 356e90ea-011b-417c-8a97-11668f0887b9